 |
|
Friday, September 11, 2026 • Your Daily Market Briefing
You are receiving this email because you are subscribed to Morning Watchlist from Behind the Markets.
If you no longer wish to receive these emails, please unsubscribe here.
|
|
Sponsored Content
|
|
This ad is sent on behalf of This has been disseminated by BioStem Technologies, Inc.
|
|
From Wound Care to the Operating Room: BSEM is Building a Bigger Regenerative Medicine Growth Story!
BioStem Technologies (NASDAQ: BSEM) is making a strategic push into one of the most compelling areas of regenerative medicine: surgical and hospital care.
The company’s BioTissue acquisition brought the Neox® and Clarix® product portfolios and expanded BSEM’s reach into hospital systems and surgical specialties, fundamentally broadening its commercial opportunity.
Management has highlighted a U.S. addressable market of approximately $26 billion, including major opportunities across orthopedics, foot and ankle, spine, urology and colorectal procedures. With hospital revenue growing and additional clinical evidence expected in 2026, BSEM is working to turn its expanded product portfolio into a larger commercial platform.
After recently uplisting to Nasdaq, BSEM is entering a new phase with greater market visibility, growing investor attention and various analyst price targets that reflect the potential analysts see in the company’s longer-term growth story.
And there could be another catalyst developing behind the scenes. BSEM plans to transition manufacturing of Neox® and Clarix® into its Florida facility, creating the potential for greater production control and margin recovery over time.
Meanwhile, the company continues expanding its sales organization, pursuing additional clinical evidence and developing new opportunities across surgical and advanced wound-care markets.
With multiple catalysts lining up across commercial growth, clinical validation, regulatory progress and manufacturing, BSEM could be quietly positioning itself for its next chapter, making it a biotech name investors may want on their radar before the story gets more widely recognized.
Learn How BSEM is Expanding its Surgical Footprint and Building the Next Phase of its Growth Story!
|
|
|
Today’s Key Points
|
|
We've made it to the end of the week — and by the time you read this, the most important number of the month is about thirty minutes old.
The August CPI hit the wire at 8:30 this morning, the last inflation reading the Fed sees before it decides on rates next Tuesday and Wednesday. This week, futures put the odds of a hike near 60%. We're still waiting for the market to digest the news, so any major effects will be covered in our Saturday issue (make sure you check your inbox tomorrow morning for the weekly recap).
While the whole week waited on that referee, three quieter stories caught our eye: a robot that just got a checkbook, a mall that refuses to die, and a mortgage rate that has quietly turned every homeowner into a repair customer.
|
|
|
|
Also on Behind the Markets
|
| ▸ |
Banned: motorcycles, milk, and whisky — The week is rounding into its final stretch, and the tape is staring at three numbers: a $100 barrel, a coin-flip Fed, and a brand-new list of banned goods. |
|
|
|
|
|
| ▸ |
Trump just threatened to ban a planemaker — We're at the midpoint of the short week, and the market came back from the holiday to find oil pressing toward $100, a September hike still live on the table — and the President threatening to ban a planemaker. |
|
|
“Buy when there’s blood in the streets, even if the blood is your own.”
— Baron Rothschild
|
|
|
|
|
We are issuing this disclosure in compliance with Section 17(b) of the Securities Act, which requires us to disclose any compensation received or expected to be received in cash or in kind in connection with the purchase or sale of any security.
This is a paid advertisement for BioStem Technologies, Inc. (BSEM). Behind the Markets will receive compensation from Sideways Frequency in connection with multiple mailings for this advertisement. Behind the Markets is paid a fixed cash fee for multiple mailings for this advertisement in the amount of $7,500. This communication is for informational and advertising purposes only and does not constitute investment advice, an offer, or a recommendation to buy or sell any security. Investors should conduct their own independent research and consult a qualified financial professional before investing.
This disclosure is made as of 09/11/2026.
You are receiving this email because you are subscribed to Morning Watchlist from Behind the Markets. If you no longer wish to receive these emails, please unsubscribe here.
For more information about our privacy practices, please review our Privacy Policy or our Legal Notices.
Our mailing address is:
Behind the Markets, LLC
4260 NW 1st Avenue, Suite 55
Boca Raton, FL 33431
Visit our website here: Behind the Markets
Copyright © 2026 Behind the Markets, LLC, All rights reserved.
|
|
